We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Nikon Instruments Displays Latest Clinical Pathology Products at AACC 2022

By LabMedica International staff writers
Posted on 27 Jul 2022

Nikon Instruments (Melville, NY, USA) will be displaying its latest clinical pathology products, including digital pathology and remote slide viewing and sharing, at the 2022 AACC Clinical Lab Expo. More...



The Nikon exhibit booth will feature ECLIPSE Ci-E upright microscope with Digital Sight 10 camera alongside the ECLIPSE Ci-L plus upright microscope with DS-Fi3 camera and NIS-Elements L tablet. To meet the demands of clinical laboratory specialists and researchers, Nikon has reviewed all aspects of microscope usability to develop the ECLIPSE Ci series of microscopes, which combines superior functionality with operational ease. The Ci is designed to ensure natural posture while viewing images, sample changing and capturing images. Bright, eco-friendly LED illumination reduces the need for frequent lamp replacement. A variety of accessories are available that support various imaging techniques.

At AACC 2022, Nikon will showcase the NIS-Elements D imaging software and NIS-Elements BR imaging software. The NIS-Elements D software package is intended for photo-documentation, and includes basic measuring and reporting tools. The NIS-Elements BR Microscope imaging software is geared for acquisition and device control for standard research applications, requiring four-dimensional imaging. Developed for standard research applications such as analysis and photodocumentation of fluorescent imaging, NIS-Elements BR features up to four-dimensional acquisition and advanced device control capabilities.

Nikon is also displaying the D-LEDI Fluorescence LED Illumination System, a long-lasting, multi-color light source for fluorescence observation. It is equipped with four LEDs (385 nm, 475 nm, 550 nm and 621 nm) to support commonly used fluorophores in fluorescence applications. The D-LEDI features a natural cooling system without the use of fans. This new design ensures a vibration-free, stable illumination source for all fluorescence imaging needs. Traditional mercury light sources require frequent lamp replacement. The D-LEDI features long-life LEDs (up to 20,000-hours) that eliminate this need.
 

Related Links:
Nikon Instruments 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
All-in-One Molecular System
AIO M160
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.